U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07600762) titled 'A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nascertib Moves Through the Body In Healthy Adult Japanese Participants' on May 14.
Brief Summary: A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nascertib Moves Through the Body In Healthy Adult Japanese Participants
Study Start Date: April 21
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: Nascertib
Oral tablet
DRUG: Placebo for Nascertib
Oral tablet
Recruitment Status: RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....